Skip to main content
B

BAOLINGBAO BIOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 002286 LEI · 836800BCV4EETAZD5488 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,980 across all filing types
Latest filing 2026-04-24 Environmental & Social …
Country CN China
Listing Shenzhen Stock Exchange 002286

About BAOLINGBAO BIOLOGY CO.,LTD.

https://www.blb-cn.com

BAOLINGBAO BIOLOGY CO.,LTD. specializes in the research, development, and large-scale production of functional sugar products. The company offers a comprehensive portfolio including prebiotics, sugar alcohols, and dietary fibers. Key products include erythritol, xylo-oligosaccharide (XOS), isomalto-oligosaccharide (IMO), polydextrose, and high fructose corn syrup. These ingredients serve diverse applications across the food, beverage, healthcare, pharmaceutical, and animal nutrition sectors. As a pioneer in the industrialization of functional sugars, the company focuses on providing health-oriented ingredient solutions, particularly in the areas of calorie reduction, digestive health, and glycemic management. Its integrated production capabilities and commitment to biotechnological innovation support its position as a global supplier of high-quality nutritional components.

Recent filings

Filing Released Lang Actions
2025年度可持续发展报告
Environmental & Social Information Classification · 1% confidence The document is a standalone “可持续发展报告” (Sustainable Development Report) covering environmental, social and governance (ESG) performance for the 2025 reporting period. It does not present full audited financial statements (10-K/Annual Report) nor is it a short announcement. It is a detailed ESG report, matching the definition of Environmental & Social Information (Code: SR).
2026-04-24 Chinese
第六届董事会独立董事专门会议第三次会议决议
Regulatory Filings Classification · 1% confidence The document is the official resolutions from a board meeting of independent directors, detailing approval of related-party transactions and authorizing a share issuance proposal. It is not an annual or interim financial report, nor an earnings release, audit report, or change in board composition. It does not present ESG, legal proceedings, or dividend notices. It also is not merely announcing publication of another report. As there is no specific category for board meeting resolutions, it falls into the general regulatory announcement fallback category: Regulatory Filings (RNS).
2026-04-24 Chinese
2025年年度报告
Regulatory Filings
2026-04-24 Chinese
关于预计与山东禹城农村商业银行股份有限公司关联交易的公告
Regulatory Filings Classification · 1% confidence The document is a formal disclosure of an anticipated related‐party transaction (affiliated bank loans and deposits) by the issuer and its board, filed under Shanghai/Shenzhen stock exchange rules. It does not present full financial results, an earnings release, nor is it a report Publication Notice or a specific capital raise/issuance announcement. It is a regulatory announcement of an affiliated transaction that does not neatly fit other specialized categories, so it defaults to the general Regulatory Filings category (RNS).
2026-04-24 Chinese
关于开展外汇套期保值业务的公告
Regulatory Filings Classification · 1% confidence The document is a standalone corporate announcement detailing the company’s board‐approved plan to conduct foreign exchange hedging (套期保值) operations, including transaction scope, risk controls, accounting treatment, and board resolutions. It is not an annual or interim financial report, earnings release, vote result, dividend notice, share issuance, or management change notice. It does not present full financial statements or call transcripts, nor is it a proxy or remuneration statement. As it does not match any highly specific category, it falls under the fallback “Regulatory Filings” category (RNS).
2026-04-24 Chinese
关于会计师事务所2025年度履职情况的评估报告
Audit Report / Information Classification · 1% confidence The document is titled “关于会计师事务所2025年度履职情况的评估报告” and is a detailed company report evaluating the performance of its appointed external auditor for the 2025 fiscal year. It describes audit procedures, independence, conclusions (including an unqualified opinion), and compliance with auditing standards. This is not the company’s Annual Report nor an announcement of such, but rather a standalone audit‐related information report. It therefore best fits the “Audit Report / Information (AR)” category.
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.